In silico Analysis of Anticancer Curcumin and its Metabolites in increasing the effectiveness of Paclitaxel
- 28 February 2023
- journal article
- research article
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 16 (2) , 885-892
Abstract
Curcuminoids are widely known to have biological activities such as antioxidant, anti-inflammatory, antiarthritis and anticancer. Even the use of curcumin has reached the first stage of clinical trials in overcoming a number of cancers. Interestingly, a number of curcumin metabolites also have anticancer effects that are equivalent to or even better than curcumin through a series of preclinical tests, but the description of their molecular interactions is still very limited so that in silico evidence is needed. QSAR and Molecular Docking were used as test methods using MOE 2008 software version 10. The research material was a 3D structure of curcumin derivative for QSAR analysis and curcumin metabolites for molecular docking analysis. Receptors downloaded from www.rscb.org include the 3D structure of MAPK, Akt, MDM2, NFkB, Cox-2, and VEGF, while the 3D structure of “human tubulin -1” was obtained from modeling. The QSAR results show that the anticancer activity of curcumin metabolites is stronger than curcumin except for dihydrocurcumin. The docking results also show that curcumin metabolites have the same affinity, even stronger than curcumin and control receptors with docking scores between 10-16kcal/mol. Curcumin and its metabolites were also able to increase the affinity of paclitaxel to the "human tubulin -1" receptor model as the target of paclitaxel's action which was characterized by an increase in the post-combination paclitaxel decking score. This study shows that curcumin is very suitable to be used as an anticancer because not only curcumin, but its metabolites also show better anticancer abilities.Keywords
This publication has 20 references indexed in Scilit:
- Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing miceFood & Function, 2017
- Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives – A reviewJournal of Traditional and Complementary Medicine, 2017
- Paclitaxel and curcumin co-bound albumin nanoparticles having antitumor potential to pancreatic cancerAsian Journal of Pharmaceutical Sciences, 2016
- Mechanism of apoptotic induction in human breast cancer cell, MCF-7, by an analog of curcumin in comparison with curcumin – An in vitro and in silico approachChemico-Biological Interactions, 2014
- New Perspectives of Curcumin in Cancer PreventionCancer Prevention Research, 2013
- In vitro and In Silico Studies on Curcumin and Its Analogues as Dual Inhibitors for cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)ITB Journal of Sciences, 2012
- Structure-based drug design to augment hit discoveryDrug Discovery Today, 2011
- Best Practices for QSAR Model Development, Validation, and ExploitationMolecular Informatics, 2010
- Deoxyelephantopin, a novel multifunctional agent, suppresses mammary tumour growth and lung metastasis and doubles survival time in miceBritish Journal of Pharmacology, 2010
- Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibitionGut, 2008